RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of beta-cell function in patients with type 2 diabetes.

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of beta-cell function in patients with type 2 diabetes.

Add to Collection
2011 Feb Others Fist_Author_Year_PM

Full Author : ['Yoon, K H', 'Shockey, G R', 'Teng, R', 'Golm, G T', 'Thakkar, P R', 'Meehan, A G', 'Williams-Herman, D E', 'Kaufman, K D', 'Amatruda, J M', 'Steinberg, H']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2011
Cited by : Not Available

AIM/HYPOTHESIS: To assess the safety and efficacy of initial combination therapy with sitagliptin and pioglitazone compared with pioglitazone monotherapy in drug-naive patients with type 2 diabetes. METHODS: A total of 520 patients were randomised to init.....

Keywords : ["initial combination therapy", "type diabetes", "glycemic control", "dipeptidyl inhibitor", "betacell function", "sitagliptin", "pioglitazone", "patient", "measure", "effect"]